-
Health Canada's special access programs: Overview
Through SAP, health care professionals may request access to drugs that are not currently authorized for sale in Canada to treat patients with serious or life-threatening... -
Applying for a licence under the Cannabis Act and Regulations
The application process for most licence classes, including the information required in an application, is set out in the Cannabis Licensing Application Guide -
Guidance documents – Contaminated sites – Environmental and workplace health
The guidance documents below are intended for use by federal government custodial departments responsible for the assessment, management and/or remediation of contaminated sites... -
Management of clinical trials during the COVID-19 pandemic: Notice to...
During the pandemic, there may be more deviations from the established protocol. Despite this, it’s important to continue to protect patient safety and ensure data integrity.... -
Nutrient Value of Some Common Foods (T7)
The Nutrient Value of Some Common Foods (NVSCF) booklet. -
Guidance for market authorization requirements for COVID-19 drugs: Quality...
COVID-19 drugs must be manufactured under good manufacturing practices (GMP) conditions. These conditions must be in line with the international requirements outlined in the... -
Nutrient Value of Some Common Foods (T3)
The Nutrient Value of Some Common Foods (NVSCF) booklet. -
Health Product InfoWatch: October 2022
This monthly publication is intended primarily for healthcare professionals and includes information on pharmaceuticals, biologics, medical devices and natural health products. -
Registration Decision RD2020-11, Inpyrfluxam, Excalia Fungicide and Zeltera Fungicide
This decision is consistent with the Proposed Registration Decision PRD2020-10, Inpyrfluxam, Excalia Fungicide and Zeltera Fungicide, which contains a detailed evaluation of the... -
Consumer Product Safety Program policy on compliance verification projects:...
This guidance document was created to provide industry with a better understanding of the Consumer Product Safety Program's (CPSP) approach to verifying compliance with the Acts... -
Priority strategies to optimize testing and quarantine at Canada’s borders
In November 2020, the Minister of Health established the COVID-19 Testing and Screening Expert Advisory Panel. The Panel provides evidence-informed advice to the federal... -
Health Canada's participation in environmental assessments
Health Canada's Role in Environmental Assessments -
Recreational water quality and health: Overview
Recreational water areas are any natural fresh, marine or estuarine (somewhat salty) bodies of water used for recreational purposes, such as: lakes, rivers, oceans human-made... -
Acetaminophen and children
Find out how children can safely be given acetaminophen. -
Cadmium in Canadians
Information on human biomonitoring of cadmium in Canada with results from the Canadian Health Measures Survey. -
1-Naphthalenemethanol, α,α-bis[4-(dimethylamino)phenyl]-4-(phenylamino)-...
Questions and answers regarding the uses of 1-Naphthalenemethanol, α,α-bis[4-(dimethylamino)phenyl]-4-(phenylamino)- (Solvent Blue 4) and actions taken to protect the public and... -
Canadian Cannabis Survey 2021: Summary
The aim of the CCS is to obtain detailed information about the habits of people who use cannabis and behaviours relative to cannabis use. -
Federal Contaminated Site Risk Assessment in Canada: Interim Guidance on...
This guidance document was prepared to provide guidance to custodians of federal contaminated sites. -
Labelling standard: Ethylene oxide gaseous products used in sterilization processes
This labelling standard applies to ethylene oxide products labelled for use as gaseous sporicides in sterilizing medical instruments/devices. It does not apply to any other... -
Summary: Packaging and labelling guide for cannabis products
This guide provides information about the packaging and labelling requirements for cannabis and cannabis products under the Cannabis Act and the Cannabis Regulations.